MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
about
Emerging therapeutic targets in esophageal adenocarcinomaMicroRNA-196a & microRNA-101 expression in Barrett's oesophagus in patients with medically and surgically treated gastro-oesophageal reflux.MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers.Salivary microRNAs as promising biomarkers for detection of esophageal cancer.miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus.Whole-miRNome profiling identifies prognostic serum miRNAs in esophageal adenocarcinoma: the influence of Helicobacter pylori infection status.MiR-203 suppresses ZNF217 upregulation in colorectal cancer and its oncogenicity.The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas.Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.Genetic factors in the pathogenesis of gastroesophageal reflux disease.Potential clinical insights into microRNAs and their target genes in esophageal carcinoma.Molecular mechanisms of Barrett's esophagus.Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma (ESCC) in patients from Huaian, China.MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.Short-segment Barrett's esophagus and cardia intestinal metaplasia: A comparative analysis.From blood to breath: New horizons for esophageal cancer biomarkers.MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1miRNAs in precancerous lesions of the gastrointestinal tract.Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas.Omeprazole Inhibits Cell Proliferation and Induces G0/G1 Cell Cycle Arrest through Up-regulating miR-203a-3p Expression in Barrett's Esophagus Cells.
P2860
Q26751209-5E97C447-6D1B-4CCD-BE48-9EBD73564502Q33830204-7DBFC2FF-9232-4894-B2D7-4E54F0CBD2BCQ34258717-6D2EE49C-210C-4474-954C-ED6B5B0B38E4Q34656109-6E46ADE7-1F20-4838-966B-350B0E00E04EQ34670849-A4C6B89C-9D20-492D-93DF-869C965CDA5DQ34917987-91101BE2-AB8C-490A-84F1-18932461E464Q35013647-9610B41D-6234-4615-B955-6FCB0AD65143Q37803216-C5459385-F40D-4BA3-BC00-17365B1E7E0FQ37822465-52D8CBF0-02C4-4DCF-964B-8EF09660150BQ37874455-76834C1A-200A-43C1-BF77-9C29CC713C56Q37922792-46B8A491-067E-4597-A5C7-2E6EA965A37FQ37943774-44BE5EAD-6578-457B-B9D2-B7A70B64B0E1Q38491448-FE8B5C0A-E403-4BAB-B782-45BC0713B547Q41426289-B414A80B-9998-4E09-B8B6-9C8D35501156Q41544625-C4D73A9B-5B5A-46BC-BBC6-854AD9B9821FQ42353202-9CEDAB95-5101-41DB-BD98-E602873FFC3AQ42557466-C6468647-12F9-4CE3-BD3F-47399EB57151Q43040562-3959D14E-36AB-4E57-9F5A-5C80D9F16937Q47166331-4E3FE36F-587C-4ACA-8E72-144F1EDE0AF9Q49632017-81ED1C66-390A-49D1-9A18-0667A7100CC5
P2860
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
MicroRNAs, development of Barr ...... to esophageal adenocarcinoma.
@en
MicroRNAs, development of Barr ...... to esophageal adenocarcinoma.
@nl
type
label
MicroRNAs, development of Barr ...... to esophageal adenocarcinoma.
@en
MicroRNAs, development of Barr ...... to esophageal adenocarcinoma.
@nl
prefLabel
MicroRNAs, development of Barr ...... to esophageal adenocarcinoma.
@en
MicroRNAs, development of Barr ...... to esophageal adenocarcinoma.
@nl
P2860
P356
P1476
MicroRNAs, development of Barr ...... n to esophageal adenocarcinoma
@en
P2093
Cameron-M Smith
Michael Z Michael
P2860
P304
P356
10.3748/WJG.V16.I5.531
P407
P577
2010-02-01T00:00:00Z